MA51582A - OLIGOMERIC CONJUGATES OF EXON JUMPING FOR MUSCLE DYSTROPHY - Google Patents
OLIGOMERIC CONJUGATES OF EXON JUMPING FOR MUSCLE DYSTROPHYInfo
- Publication number
- MA51582A MA51582A MA051582A MA51582A MA51582A MA 51582 A MA51582 A MA 51582A MA 051582 A MA051582 A MA 051582A MA 51582 A MA51582 A MA 51582A MA 51582 A MA51582 A MA 51582A
- Authority
- MA
- Morocco
- Prior art keywords
- muscle dystrophy
- oligomeric conjugates
- exon
- jumping
- exon jumping
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Psychology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662436223P | 2016-12-19 | 2016-12-19 | |
PCT/US2017/066509 WO2018118662A1 (en) | 2016-12-19 | 2017-12-14 | Exon skipping oligomer conjugates for muscular dystrophy |
Publications (2)
Publication Number | Publication Date |
---|---|
MA51582A true MA51582A (en) | 2019-10-23 |
MA51582B1 MA51582B1 (en) | 2022-10-31 |
Family
ID=65895705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA51582A MA51582B1 (en) | 2016-12-19 | 2017-12-14 | Exon skipping oligomer conjugates for muscular dystrophy |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR110390A1 (en) |
MA (1) | MA51582B1 (en) |
-
2017
- 2017-12-14 MA MA51582A patent/MA51582B1/en unknown
- 2017-12-18 AR ARP170103553A patent/AR110390A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA51582B1 (en) | 2022-10-31 |
AR110390A1 (en) | 2019-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA55629A (en) | ANTIBODY COMPOSITIONS FOR THE TREATMENT OF TUMORS | |
MA44486A (en) | EARLY INTERVENTION METHODS TO PREVENT OR MITIGATE TOXICITY | |
MA46652A (en) | POLYTHERAPY FOR C3 INHIBITION | |
MA44054A (en) | BISPECIFIC ANTIBODY PLATFORM | |
MA46878A (en) | BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS | |
MA52801A (en) | OLIGOMERIC CONJUGATES TO EXON SKIP FOR MUSCLE DYSTROPHY | |
MA46048A (en) | BEGINNER KIT FOR TITRATION OF BASIC INSULIN | |
MA50533A (en) | IMIPRIDONES FOR GLIOMAS | |
FR3034840B3 (en) | FLEXIBLE LIGHTING ASSEMBLY FOR CURVED VENTS | |
FR3016407B1 (en) | TRAINING BOX FOR EQUIPMENT | |
FR3018964B1 (en) | INTERCONNECTION ELEMENT FOR CONNECTING STATOR COILS | |
FR3023015B1 (en) | METHOD FOR FACILITATING THE APPROACH TO A PLATFORM | |
MA45845A (en) | COMBINATION TREATMENT FOR HEMATOLOGICAL CANCERS | |
FR3031502B1 (en) | POINT SET FOR AN INSTRUMENT | |
FR3028523B1 (en) | PROCESS FOR IMPROVING THE COKEFACTION RESISTANCE OF A LUBRICATING COMPOSITION | |
MA51822A (en) | ALKANOIC ACID EXTRACTION | |
FR3031206B1 (en) | INTERCONNECTION BOX FOR UTILITIES | |
FR3030253B1 (en) | COMPOSITION FOR IMPROVING THE CELLULAR ASPECT OF THE SKIN | |
MA46898A (en) | COMPOSITIONS FOR ORGAN CONSERVATION | |
FR3033489B3 (en) | GUIDE FOR THE POSITIONING OF ORTHODONTIC ATTACHES | |
MA47015A (en) | OLIGOMERIC CONJUGATES OF EXON JUMPING FOR MUSCLE DYSTROPHY | |
MA51582A (en) | OLIGOMERIC CONJUGATES OF EXON JUMPING FOR MUSCLE DYSTROPHY | |
MA51587A (en) | OLIGOMERIC CONJUGATES OF EXON JUMPING FOR MUSCLE DYSTROPHY | |
MA42048A (en) | AMINOESTERS DERIVATIVES | |
FR3046235B1 (en) | INTERCHANGEABLE SUPPORT FOR FASTENING A TURBOMACHINE |